| dc.description.abstract | Artemisinin-based combination therapy (ACT) has been adopted as the most
effective treatment against malaria in many endemic countries like Kenya while quinine has
remained the second line. The objective of the current study was to assess access to
Kenya's policy recommended anti-malarials, ACT and quinine in the public, private and not-
for-profit drug outlets in western Kenya. Methods A cross-sectional survey using purposive
sampling of 288 outlets (126 public, 96 private, 66 not-for-profit) was conducted in western
Kenya in two regions with varying Plasmodium falciparum endemicities. Information on
access (availability, price, affordability) on ACT and quinine was collected using the WHO
and Healthcare Associated Infection (HAI) standardized methodologies for availability,
prices and affordability of drugs. From a Ministry of Health database, the following were … | en_US |
